---
layout: default
title: publications 
permalink: /publications/
---

#### Selected Publications 

[TCF21 and the environmental sensor aryl-hydrocarbon receptor cooperate to activate a pro-inflammatory gene expression program in coronary artery smooth muscle cells.][26] PLOS Genetics. 2017 May 8;13(5):e1006750.

Miller CL† and Leeper NJ. [GWAS candidate gene to dual modifier of non-alcoholic fatty liver disease and atherosclerosis.][1] Journal of the American College of Cardiology: Basic to Translational Science. 2016.(† corresponding author)   

Pjanic M, Miller CL, Wirka R, Kim BK, DiRenzo D, Quertermous T. [Genetics and genomics of coronary artery disease.][3] Current Cardiology Reports. 2016. Oct;18(10):102.

Perisic L, Rykaczewska U, Razuvaev A, Sabater-Lleal M, Lengquist M, Miller CL, Eriksson I, Röhl S, Aldi S, Kronqvist M, Gonzalez Diez M, Roy J, Baldassarre D, Veglia F, Humphries SE, de Faire, U, Tremoli E, IMPROVE study group, Odeberg J, Vukojevic V, Paulsson-Berne G, Hansson GK, Lindeman JHN, Eriksson P, Quertermous T, Hamsten A, Hedin U. [Phenotypic modulation of smooth muscle cells in atherosclerosis is associated with downregulation of LMOD1, SYNPO2, PDLIM7, PLN and SYNM.][4] Arteriosclerosis, Thrombosis and Vascular Biology. 2016 Sep;36(9):1947-61. 

Kojima Y‡, Volkmer JP, McKenna K, Civelek M, Lusis AJ, Miller CL, DiRenzo D, Nanda V, Brady S, Connelly AP, Schadt EE, Quertermous T, Betancur PA, Maegdefessel L, Perisic L, Hedin U, Weissman I, Leeper NJ. [CD47 blocking antibodies restore phagocytosis and prevent atherosclerosis.][5] Nature. 2016 Aug 4;536(7614):86-90. (‡ manuscript received editorial)

Miller CL†, Pjanic M, Wang T, Nguyen T, Cohain A, Lee JD, Perisic L, Hedin U, Kundu RK, Majmudar D, Kim JB, Wang O, Betsholtz C, Ruusalepp A, Franzen O, Assimes TL, Montgomery SB, Schadt EE, Björkegren J, Quertermous T. [Integrative functional genomics identifies regulatory mechanisms at coronary heart disease loci.][6] Nature Communications. 2016 Jul 8;7:12092. († corresponding author)  

Miller CL, Pjanic M, Quertermous T. [From locus association to mechanism of gene causality: the devil is in the details.][9] Arteriosclerosis, Thrombosis and Vascular Biology. 2015 Oct;35(10):2079-80.

Nürnberg ST, Cheng K, Raiesdana A, Kundu RK, Miller CL, Arora K, Carcamo-Oribe I, Xiong Y, Kim JB, Tellakula N, Murthy N, Bolsvert WA, Owens GK, Tallquist MD, Quertermous T. [TCF21 regulates smooth muscle cell precursor cells that contribute to the fibrous cap.][10] PLOS Genetics. 2015 May 28;11(5):e1005155.

Sazonova OV, Zhao Y, Nürnberg ST, Miller CL, Pjanic M, Kundaje AB, Bejerano G, Assimes TL, Yang X, Quertermous T. [Characterization of TCF21 downstream target regions identifies a transcriptional pathway linking multiple independent coronary heart disease loci.][11] PLOS Genetics. 2015 May 28;11(5):e1005202. 

Miller CL†, Haas U, Diaz R, Leeper NJ, Kundu RK, Patolla B, Assimes TL, Kaiser FJ, Ljubica P, Hedin U, Maegdefessel L, Schunkert H, Erdmann J, Quertermous T†, Sczakiel G†. [Coronary heart disease-associated variation in TCF21 disrupts a miR-224 binding site and miRNA-mediated regulation.][12] PLOS Genetics. 2014 Mar 27; 10(3):e1004263. († corresponding author)

Miller CL, Assimes TL, Montgomery SB, Quertermous T. [Dissecting the causal genetic mechanisms of coronary heart disease. Current Atherosclerosis Reports.][13] 2014 May;16(5):406.

Kojima Y, Downing KP, Kundu RK, Miller CL, Dewey F, Lancero H, Raaz U, Perisic L, Hedin U, Schadt EE, Maegdefessel L, Quertermous T, Leeper NJ. [CDKN2B regulates efferocytosis and atherosclerosis.][14] Journal of Clinical Investigation. 2014 Mar 3;124(3):1083-97. 

Miller CL†, Anderson DR, Kundu RK, Raiesdana A, Nürnberg ST, Diaz R, Cheng K, Leeper NJ, Chen CH, Chang IS, Schadt EE, Hsiung CA, Assimes TL, Quertermous T†. [Disease-related growth factor and embryonic signaling pathways modulate an enhancer of TCF21 expression at the 6q23.2 coronary heart disease locus.][15] PLOS Genetics. 2013 Jul;9(7):e1003652. († corresponding author)

Leeper NJ, Raiesdana A, Kojima Y, Kundu RK, Cheng H, Maegdefessel L, Toh R, Ahn GO, Ali ZA, Anderson DR, Miller CL, Roberts SC, Spin JM, de Almeida PE, Wu JC, Xu B, Cheng K, Quertermous M, Kundu S, Kortekaas KE, Berzin E, Downing KP, Dalman RL, Tsao PS, Schadt EE, Owens GK, Quertermous T. [Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation.][16] Arteriosclerosis, Thrombosis and Vascular Biology. 2013 Jan;33(1):e1-e10. 

Miller CL, Oikawa M, Cai Y, Thomas T, Dostmann W, Zaccolo M, Fujiwara K, Yan C. [Cyclic nucleotide phosphodiesterase 1: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart.][17] Basic Research in Cardiology. 2011 Nov;106(6): 1023-39.  

Cai Y, Miller CL, Nagel DJ, Jeon KI, Lim S, Gao P, Knight PA, Yan C. [Cyclic nucleotide phosphodiesterase 1 regulates lysosome-dependent type I collagen protein degradation in vascular smooth muscle cells.][18] Arteriosclerosis, Thrombosis and Vascular Biology. 2010 Dec 9;31(3): 616-23. 

Miller CL, Yan C. [Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications.][20] Journal of Cardiovascular Translational Research. 2010 Oct;3(5): 507-15. 

Miller CL‡, Oikawa M, Cai Y, Wojtovich AP, Nagel DJ, Xu X, Xu, H, Rybalkin SD, Beavo JA, Chen YF, Li JD, Blaxall BC, Abe J, Yan C. [Role of Ca2+/CaM-stimulated phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.][21] Circulation Research. 2009 Nov 6;105(10): 956-64. (‡ manuscript received editorial) 

Yan C, Miller CL, Abe J. [Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart.][22] Circulation Research. 2007 Mar 2;100(4): 489-501.

[1]: http://www.basictranslational.onlinejacc.org/content/1/7/680
[3]: http://link.springer.com/article/10.1007%2Fs11886-016-0777-y
[4]: http://atvb.ahajournals.org/content/early/2016/07/28/ATVBAHA.116.307893
[5]: http://www.nature.com/nature/journal/v536/n7614/full/nature18935.html
[6]: http://www.nature.com/articles/ncomms12092
[9]: http://atvb.ahajournals.org/content/35/10/2079.long
[10]: http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1005155
[11]: http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1005202
[12]: http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1004263
[13]: http://link.springer.com/article/10.1007%2Fs11883-014-0406-4
[14]: https://www.jci.org/articles/view/70391
[15]: http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1003652
[16]: http://atvb.ahajournals.org/content/33/1/e1.long
[17]: http://link.springer.com/article/10.1007%2Fs00395-011-0228-2
[18]: http://atvb.ahajournals.org/content/31/3/616.long
[20]: http://link.springer.com/article/10.1007%2Fs12265-010-9203-9
[21]: http://circres.ahajournals.org/content/105/10/956.long
[22]: http://circres.ahajournals.org/content/100/4/489.long
[26]: http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1006750


#### Additional Publications

Knight W, Chen S, Zhang Y, Oikawa M, Wu M, Zhou Q, Miller CL, Cai Y, Mickelsen D, Moravec C, Small EM, Abe JI, Yan C. [PDE1C deficiency antagonizes pathological cardiac remodeling and dysfunction.][2] Proceedings of the National Academy of Sciences USA. 2016 Oct 20. pii: 201607728. 

Pjanic M, Miller CL, Quertermous T. [Transcription factor regulation as a mechanism of confounding effects between distinct human traits.][23] F1000Research. 2015 4:1349. 

Perez MV‡, Pavlovic A, Shang C, Wheeler MT, Miller CL, Liu J, Dewey FE, Pan S, Thanaporn P, Absher D, Brandimarto J, Salisbury H, Chan K, Mukherjee R, Konadhone R, Myers RM, Sedehi D Scammell T, Quertermous T, Cappola T, Ashley EA. [Systems genomics identifies a key role for hypocretin/orexin receptor 2 in human heart failure.][7] Journal of the American College of Cardiology. 2015;66(22):2522-2533. (‡ manuscript received editorial)

Dewey FE, Grove ME, Priest JR, Waggott D, Batra P, Miller CL, Wheeler MT, Zia A, Pan C, Karzcewski KJ, Miyake C, Whirl-Carrillo M, Klein T, Datta S, Altman R, Snyder M, Quertermous T, Ashley EA. [Sequence to medical phenotypes: a framework for identifying clinical phenotypes in whole genome DNA sequence data.][8] PLOS Genetics. 2015 Oct 8;11(10):e1005496. 

Oikawa M, Wu M, Lim S, Knight W, Miller CL, Cai Y, Yan Lu Y, Blaxall BC, Takeishi Y, Abe JI, Yan C. [Cyclic nucleotide phosphodiesterase 3A1 protects the heart against ischemia-reperfusion injury.][24] Journal of Molecular and Cellular Cardiology. 2013 Aug 27;64C:11-19.

Jeon KI, Jono H, Miller CL, Cai Y, Lim S, Gao P, Abe J, Li JD, Yan C. [Ca2+/calmodulin-stimulated PDE1A regulates beta-catenin/TCF signaling through PP2A B56 in synthetic VSMCs.][19] FEBS Journal. 2010 Dec;277(24): 5026-39. 

Hahn K, Sirdofsky M, Brown A, Ebenezer G, Hauer P, Miller CL, Polydefkis M. [Collateral sprouting of human epidermal nerve fibers following intracutaneous axotomy.][25] Journal of the Peripheral Nervous System. 2006 Jun;11(2): 142-7. 

[2]: http://www.pnas.org/content/113/45/E7116.full
[7]: http://www.onlinejacc.org/content/66/22/2522
[8]: http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1005496
[19]: http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1742-4658.2010.07908.x/abstract
[23]: https://f1000research.com/articles/4-1349/v1
[24]: http://www.sciencedirect.com/science/article/pii/S0022282813002563
[25]: http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1085-9489.2006.00079.x/abstract
